Works by Barrios, Carlos H.

Results: 28

The Good Example: Potential of Clinical Research to Expand Quality Care in Low- and Middle-Income Countries.

Published in:

American Journal of Bioethics, 2016, v. 16, n. 6, p. 22, doi. 10.1080/15265161.2016.1170246

By:

Barrios, Carlos H.

Publication type:

Article

Enhancing global access to cancer medicines.

Published in:

2020

By:

Cortes, Javier;
Perez‐García, Jose Manuel;
Llombart‐Cussac, Antonio;
Curigliano, Giuseppe;
El Saghir, Nagi S.;
Cardoso, Fatima;
Barrios, Carlos H.;
Wagle, Shama;
Roman, Javier;
Harbeck, Nadia;
Eniu, Alexandru;
Kaufman, Peter A.;
Tabernero, Josep;
García‐Estévez, Laura;
Schmid, Peter;
Arribas, Joaquín;
Perez-García, Jose Manuel;
Llombart-Cussac, Antonio;
García-Estévez, Laura

Publication type:

journal article

Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions from the 4th CURA meeting, São Paulo, 2023.

Published in:

Ecancermedicalscience, 2024, v. 18, n. 1706-1753, p. 1, doi. 10.3332/ecancer.2024.1698

By:

Resende, Heloisa;
Arai, Roberto J.;
Barrios, Carlos H.;
Schwyter, Fernanda;
Teich, Nelson L. S.;
Gomes, Andre;
Dallari, Analluza B.;
Bonilha, Laís A. S.;
Souza, Claudiosvam M. A.;
Francisco, Fernando R.;
Munhoz, Rodrigo R.;
Werutsky, Gustavo;
Madi, Marisa;
Fernandes, Paulo;
Figueiredo, Jose M.;
Fedozzi, Fabio;
Arruda, Lilian;
Aguiar, Vinícius Q.;
Melo, Andreia C.

Publication type:

Article

Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions from the 4th CURA meeting, São Paulo, 2023.

Published in:

Ecancermedicalscience, 2024, v. 18, n. 1675-1705, p. 1, doi. 10.3332/ecancer.2024.1698

By:

Resende, Heloisa;
Arai, Roberto J.;
Barrios, Carlos H.;
Schwyter, Fernanda;
Teich, Nelson L. S.;
Gomes, Andre;
Dallari, Analluza B;
Bonilha, Laís A. S.;
Souza, Claudiosvam M. A.;
Francisco, Fernando R.;
Munhoz, Rodrigo R.;
Werutsky, Gustavo;
Madi, Marisa;
Fernandes, Paulo;
Figueiredo, Jose M.;
Fedozzi, Fabio;
Arruda, Lilian;
Aguiar, Vinícius Q.;
Melo, Andreia C.

Publication type:

Article

Clinical validation and diagnostic accuracy of 99mTc-EDDA/HYNIC-TOC compared to 111In-DTPA-octreotide in patients with neuroendocrine tumours: the LACOG 0214 study.

Published in:

Ecancermedicalscience, 2023, v. 17, n. 1551-1584, p. 1, doi. 10.3332/ecancer.2023.1582

By:

Moriguchi-Jeckel, Cristina M.;
Madke, Rafael R.;
Radaelli, Graciane;
Viana, Alice;
Nabinger, Patrícia;
Fernandes, Bruna;
Gössling, Gustavo;
Berdichevski, Eduardo H.;
Vilas, Eduardo;
Giacomazzi, Juliana;
Rocha, Matheus Soares;
Borges, João Alfredo;
Hoffmann, Elias;
Greggio, Samuel;
Venturin, Gianina T.;
Barrios, Carlos H.;
Zaffaroni, Facundo;
Werutsky, Gustavo;
da Costa, Jaderson C.

Publication type:

Article

Evaluation of an Implantable Venous Access System in a General Oncology Population.

Published in:

Oncology, 1992, v. 49, n. 6, p. 474, doi. 10.1159/000227095

By:

Barrios, Carlos H.;
Zuke, Jeffrey E.;
Blaes, Barbara;
Hirsch, John D.;
Lyss, Alan P.

Publication type:

Article

Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?

Published in:

NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00328-3

By:

Weis, Luiza N.;
Tolaney, Sara M.;
Barrios, Carlos H.;
Barroso-Sousa, Romualdo

Publication type:

Article

Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355.

Published in:

JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 5, p. 717, doi. 10.1093/jnci/djad240

By:

Cescon, David W;
Schmid, Peter;
Rugo, Hope S;
Im, Seock-Ah;
Yusof, Mastura Md.;
Gallardo, Carlos;
Lipatov, Oleg;
Barrios, Carlos H;
Perez-Garcia, Jose;
Iwata, Hiroji;
Masuda, Norikazu;
Otero, Marco Torregroza;
Gokmen, Erhan;
Loi, Sherene;
Haiderali, Amin;
Zhou, Xuan;
Guo, Zifang;
Nguyen, Allison Martin;
Cortes, Javier

Publication type:

Article

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.

Published in:

2021

By:

Chan, Arlene;
Moy, Beverly;
Mansi, Janine;
Ejlertsen, Bent;
Holmes, Frankie Ann;
Chia, Stephen;
Iwata, Hiroji;
Gnant, Michael;
Loibl, Sibylle;
Barrios, Carlos H.;
Somali, Isil;
Smichkoska, Snezhana;
Martinez, Noelia;
Garcia-Alonso, Mirta;
Link, John S.;
Mayer, Ingrid A.;
Cold, Søren;
Morales Murillo, Serafin;
Senecal, Francis;
Inoue, Kenichi

Publication type:

journal article

A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).

Published in:

2016

By:

Gómez, Henry L.;
Neciosup, Silvia;
Tosello, Célia;
Mano, Max;
Bines, José;
Ismael, Gustavo;
Santi, Patrícia X.;
Pinczowski, Hélio;
Nerón, Yeni;
Fanelli, Marcello;
Fein, Luis;
Sampaio, Carlos;
Lerzo, Guillermo;
Capó, Adolfo;
Zarba, Juan J.;
Blajman, César;
Varela, Mirta S.;
Martínez-Mesa, Jeovany;
Werutsky, Gustavo;
Barrios, Carlos H.

Publication type:

journal article

Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: review.

Published in:

Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 11, p. 693, doi. 10.1177/1758834017728928

By:

Reinert, Tomás;
Barrios, Carlos H.

Publication type:

Article

Optimal management of hormone receptor positive metastatic breast cancer in 2016.

Published in:

Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 6, p. 304, doi. 10.1177/1758834015608993

By:

Reinert, Tomas;
Barrios, Carlos H.

Publication type:

Article

Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.

Published in:

2019

By:

Perez, Edith A.;
de Haas, Sanne Lysbet;
Eiermann, Wolfgang;
Barrios, Carlos H.;
Toi, Masakazu;
Im, Young-Hyuck;
Conte, Pier Franco;
Martin, Miguel;
Pienkowski, Tadeusz;
Pivot, Xavier B.;
Burris III, Howard A.;
Stanzel, Sven;
Patre, Monika;
Ellis, Paul Anthony;
Burris, Howard A 3rd

Publication type:

journal article

ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor–Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy.

Published in:

Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00342

By:

Reinert, Tomás;
Ramalho, Susana;
de Vasconcelos, Vivian Castro Antunes;
Silva, Leonardo Roberto;
da Silva, Ana Elisa Ribeiro;
de Andrade, Camila Annicchino;
Kraft, Maria Beatriz de Paula Leite;
Coelho, Guilherme Portela;
Mandelli, Jovana;
Binotto, Monique;
Cabello, Cesar;
Paiva Silva, Geisilene Russano de;
Bines, José;
Barrios, Carlos H.;
Ellis, Matthew J.;
Graudenz, Marcia Silveira

Publication type:

Article

Towards Smart-City Implementation for Crisis Management in Fast-Growing and Unplanned Cities: The Colombian Scenario.

Published in:

Ingeniería y Ciencia, 2020, v. 16, n. 32, p. 151, doi. 10.17230/ingciencia.16.32.7

By:

Puentes, Michael;
Arroyo, Irene;
Carrillo, Oscar;
Barrios H., Carlos J.;
Le Mouël, Frédéric

Publication type:

Article

Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.

Published in:

2019

By:

Perez, Edith A.;
de Haas, Sanne Lysbet;
Eiermann, Wolfgang;
Barrios, Carlos H.;
Toi, Masakazu;
Im, Young-Hyuck;
Conte, Pier Franco;
Martin, Miguel;
Pienkowski, Tadeusz;
Pivot, Xavier B.;
Burris III, Howard A.;
Stanzel, Sven;
Patre, Monika;
Ellis, Paul Anthony;
Burris, Howard A 3rd

Publication type:

journal article

PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: a diagnostic test study (LACOG 0114).

Published in:

2019

By:

Werutsky, Gustavo;
Hochhegger, Bruno;
Lopes de Figueiredo Pinto, José Antônio;
Martínez-Mesa, Jeovany;
Zanini, Mara Lise;
Berdichevski, Eduardo Herz;
Vilas, Eduardo;
da Silva, Vinícius Duval;
Tsukazan, Maria Teresa Ruiz;
Vieira, Arthur;
Fritscher, Leandro Genehr;
Hartmann, Louise;
Alba, Marcos;
Sartori, Guilherme;
Matushita, Cristina;
Bortolotto, Vanessa;
do Amaral, Rayssa Ruszkowski;
Junior, Luís Carlos Anflor;
Zaffaroni, Facundo;
Barrios, Carlos H.

Publication type:

journal article

Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.

Published in:

2018

By:

Wu, Yi-Long;
Sequist, Lecia V;
Tan, Eng-Huat;
Geater, Sarayut L;
Orlov, Sergey;
Zhang, Li;
Lee, Ki Hyeong;
Tsai, Chun-Ming;
Kato, Terufumi;
Barrios, Carlos H;
Schuler, Martin;
Hirsh, Vera;
Yamamoto, Nobuyuki;
O'Byrne, Kenneth;
Boyer, Michael;
Mok, Tony;
Peil, Barbara;
Märten, Angela;
Chih-Hsin Yang, James;
Paz-Ares, Luis

Publication type:

journal article

Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 5839, doi. 10.2147/OTT.S109445

By:

Barrios, Carlos H.;
Herchenhorn, Daniel;
Chacón, Matías;
Cabrera-Galeana, Paula;
Sajben, Peter;
Ke Zhang

Publication type:

Article

Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2023, v. 15, p. 1, doi. 10.1177/17588359231178125

By:

Slamon, Dennis J.;
Fasching, Peter A.;
Hurvitz, Sara;
Chia, Stephen;
Crown, John;
Martín, Miguel;
Barrios, Carlos H.;
Bardia, Aditya;
Im, Seock-Ah;
Yardley, Denise A.;
Untch, Michael;
Huang, Chiun-Sheng;
Stroyakovskiy, Daniil;
Xu, Binghe;
Moroose, Rebecca L.;
Loi, Sherene;
Visco, Frances;
Bee-Munteanu, Valerie;
Afenjar, Karen;
Fresco, Rodrigo

Publication type:

Article

Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study.

Published in:

PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0202865

By:

Lee, Dae Ho;
Tsao, Ming-Sound;
Kambartel, Karl-Otto;
Isobe, Hiroshi;
Huang, Ming-Shyan;
Barrios, Carlos H.;
Khattak, Adnan;
de Marinis, Filippo;
Kothari, Smita;
Arunachalam, Ashwini;
Cao, Xiting;
Burke, Thomas;
Valladares, Amparo;
de Castro, Javier

Publication type:

Article

Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma.

Published in:

Cancer (0008543X), 2012, v. 118, n. 5, p. 1252, doi. 10.1002/cncr.26440

By:

Barrios, Carlos H.;
Hernandez-Barajas, David;
Brown, Michael P.;
Lee, Se-Hoon;
Fein, Luis;
Liu, Jin-Hwang;
Hariharan, Subramanian;
Martell, Bridget A.;
Yuan, Jinyu;
Bello, Akintunde;
Wang, Zhixiao;
Mundayat, Rajiv;
Rha, Sun-Young

Publication type:

Article

Clinical implications of eSR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer.

Published in:

Frontiers in Oncology, 2017, v. 7, p. 1, doi. 10.3389/fonc.2017.00026

By:

Reinert, Tomas;
Saad, Everardo D.;
Barrios, Carlos H.;
Bines, José

Publication type:

Article

PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer.

Published in:

2021

By:

Rugo, Hope S;
Loi, Sherene;
Adams, Sylvia;
Schmid, Peter;
Schneeweiss, Andreas;
Barrios, Carlos H;
Iwata, Hiroji;
Diéras, Véronique;
Winer, Eric P;
Kockx, Mark M;
Peeters, Dieter;
Chui, Stephen Y;
Lin, Jennifer C;
Nguyen-Duc, Anh;
Viale, Giuseppe;
Molinero, Luciana;
Emens, Leisha A;
Duc, Anh Nguyen

Publication type:

journal article

Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study.

Published in:

2021

By:

Emens, Leisha A;
Molinero, Luciana;
Loi, Sherene;
Rugo, Hope S;
Schneeweiss, Andreas;
Diéras, Véronique;
Iwata, Hiroji;
Barrios, Carlos H;
Nechaeva, Marina;
Nguyen-Duc, Anh;
Chui, Stephen Y;
Husain, Amreen;
Winer, Eric P;
Adams, Sylvia;
Schmid, Peter

Publication type:

journal article

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.

Published in:

2019

By:

Lambertini, Matteo;
Campbell, Christine;
Bines, José;
Korde, Larissa A;
Izquierdo, Miguel;
Fumagalli, Debora;
Mastro, Lucia Del;
Ignatiadis, Michail;
Pritchard, Kathleen;
Wolff, Antonio C;
Jackisch, Christian;
Lang, Istvan;
Untch, Michael;
Smith, Ian;
Boyle, Frances;
Xu, Binghe;
Barrios, Carlos H;
Baselga, José;
Moreno-Aspitia, Alvaro;
Piccart, Martine

Publication type:

journal article

PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.

Published in:

2019

By:

Chia, Stephen K. L.;
Martin, Miguel;
Holmes, Frankie A.;
Ejlertsen, Bent;
Delaloge, Suzette;
Moy, Beverly;
Iwata, Hiroji;
von Minckwitz, Gunter;
Mansi, Janine;
Barrios, Carlos H.;
Gnant, Michael;
Tomašević, Zorica;
Denduluri, Neelima;
Šeparović, Robert;
Kim, Sung-Bae;
Jakobsen, Erik Hugger;
Harvey, Vernon;
Robert, Nicholas;
Smith II, John;
Harker, Graydon

Publication type:

journal article

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy.

Published in:

2017

By:

Musolino, Antonino;
Campone, Mario;
Neven, Patrick;
Denduluri, Neelima;
Barrios, Carlos H.;
Cortes, Javier;
Blackwell, Kimberly;
Soliman, Hatem;
Kahan, Zsuzsanna;
Bonnefoi, Hervé;
Squires, Matthew;
Zhang, Yong;
Deudon, Stephanie;
Shi, Michael M.;
André, Fabrice

Publication type:

journal article

Works by Barrios, Carlos H.

The Good Example: Potential of Clinical Research to Expand Quality Care in Low- and Middle-Income Countries.

Enhancing global access to cancer medicines.

Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions from the 4th CURA meeting, São Paulo, 2023.

Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions from the 4th CURA meeting, São Paulo, 2023.

Clinical validation and diagnostic accuracy of <sup>99m</sup>Tc-EDDA/HYNIC-TOC compared to <sup>111</sup>In-DTPA-octreotide in patients with neuroendocrine tumours: the LACOG 0214 study.

Evaluation of an Implantable Venous Access System in a General Oncology Population.

Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?

Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355.

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.

A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).

Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: review.

Optimal management of hormone receptor positive metastatic breast cancer in 2016.

Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.

ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor–Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy.

Towards Smart-City Implementation for Crisis Management in Fast-Growing and Unplanned Cities: The Colombian Scenario.

Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.

PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: a diagnostic test study (LACOG 0114).

Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.

Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma.

Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer.

Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study.

Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma.

Clinical implications of eSR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer.

PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer.

Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study.

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.

PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR<sup>+</sup>, HER2<sup>-</sup> breast cancer that had progressed during or after prior endocrine therapy.